ARCHIVES

Individualized Cancer Vaccines Show 90% Survival at 6 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

New Chemotherapy, Other Modality Progress Described

March 30, 1979

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001